Schizoaffective Disorders Withdrawn Phase 2 Trials for Cholecalciferol (DB00169)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02197286Targeted Vitamin D Treatment of Schizophrenia-Associated HyperprolinemiaTreatment